Neuro-Rehabilitation · Spasticity Assessment · Clinical Standard

Modified Ashworth Scale Calculator

Grade spasticity and muscle tone across upper and lower extremity muscle groups. Includes clonus and contracture flags, intensity classification, and EMR-ready neurological documentation.

Clinically reviewed by Dr. Nikhil Mahajan, PT, MPT  ·  Jan 15, 2025
0 No increase in muscle tone
1 Slight increase — catch & release at end ROM
1+ Catch then resistance through <50% ROM
2 More marked increase — limb easily moved
3 Considerable increase — passive movement difficult
4 Limb rigid in flexion or extension

Perform passive movement at the speed of gravity (approximately 1 second per joint). Consistent speed is critical for reliable, comparable scores.

Muscles Scored 0 /14
Avg Grade 0.0 / 4
Peak Grade 0 / 4
Intensity Normal

Upper Extremity

7 muscle groups — passive movement at speed of gravity

0 scored
Elbow Flexors Biceps, brachialis
Elbow Extensors Triceps
Wrist Flexors FCR, FCU
Wrist Extensors ECRL, ECRB
Finger Flexors FDP, FDS
Finger Extensors EDC
Shoulder Adductors Pec major, lat dorsi

Lower Extremity

7 muscle groups — include hip, knee and ankle

0 scored
Hip Flexors Iliopsoas
Hip Adductors Adductor group
Hip Extensors Gluteus maximus
Knee Extensors Quadriceps
Knee Flexors Hamstrings
Ankle Plantarflexors Gastrocnemius, soleus
Ankle Dorsiflexors Tibialis anterior

Additional Clinical Signs

Modified Ashworth Scale Grade Reference

Grade Description Clinical Characteristics Typical Intervention
0 No increase in tone Passive movement meets no resistance throughout ROM No pharmacological intervention needed
1 Slight increase — catch at end ROM Brief catch and release at end of ROM only Stretching program, positioning
1+ Catch then resistance <50% ROM Catch followed by minimal resistance through <half of ROM Stretching, splinting, oral medication consideration
2 Marked increase — limb movable Resistance throughout most of ROM; limb still easily moved Oral antispasmodics, Botox consideration
3 Considerable increase — movement difficult Passive movement is difficult; significant resistance throughout Botox / Baclofen threshold — pharmacological intervention often required
4 Rigid in flexion or extension Affected part rigid; passive movement nearly impossible Intrathecal baclofen, surgical neurectomy, intensive management

What is the Modified Ashworth Scale?

The Modified Ashworth Scale (MAS) is a 6-point ordinal clinical assessment tool used to grade spasticity and muscle tone by measuring resistance felt during passive movement of a limb through its range of motion. Originally developed as the Ashworth Scale in 1964, it was modified by Bohannon and Smith (1987) to add the intermediate grade 1+ — creating the current 6-level scale. The MAS is the most widely used clinical spasticity assessment tool in neurological rehabilitation, used to evaluate patients with stroke, spinal cord injury, multiple sclerosis, cerebral palsy, and traumatic brain injury.

Understanding MAS Grade 1+

The 1+ grade is the most clinically important modification from the original scale. It distinguishes between:

  • Grade 1 — A catch that occurs only at the very end of ROM and then releases. The limb moves freely through most of its range.
  • Grade 1+ — A catch that is followed by sustained but minimal resistance through less than half of the remaining ROM. This indicates more persistent but still mild hypertonia.

This distinction is clinically significant because grade 1+ often warrants intervention (stretching, splinting, oral medication) while grade 1 typically does not.

How to Administer the MAS

  • Speed: Passive movement must be performed at a consistent speed — approximately the speed of gravity (1 second per joint movement). Spasticity is velocity-dependent; faster movement elicits more response, slower movement less.
  • Position: Patient must be in a standardized, comfortable position. Arousal level, pain, and body temperature all affect spasticity scores.
  • Direction: For flexor spasticity (most common post-stroke), move from flexion to extension. Document the direction clearly.
  • Timing: Assess in the morning and at rest for consistent baseline measurements. Spasticity varies throughout the day.
  • Documentation: Record specific muscle group, grade, side (left/right), position, and any additional signs (clonus, clonus beats, contracture).

Clinical Applications & Populations

  • Post-stroke spasticity — Most common application; affects ~40% of stroke survivors. Elbow flexors and wrist flexors most commonly affected in UE; plantarflexors in LE.
  • Spinal cord injury — Documents both upper and lower extremity tone; guides antispasticity medication titration.
  • Multiple sclerosis — Monitors tone fluctuation with disease progression and heat sensitivity.
  • Cerebral palsy — Used in pediatric populations to justify and monitor Botulinum toxin injections and surgical outcomes (SDR, ITB pump).
  • Traumatic brain injury — Guides early splinting decisions and antispasticity pharmacology in ICU and rehabilitation phases.

MAS Score ≥ 3 — US Insurance Threshold

In the US healthcare system, documented MAS scores of 3 or above are often required by insurance providers as a prerequisite for authorization of:

  • Botulinum toxin (Botox) injections — For focal spasticity reduction in specific muscle groups
  • Intrathecal baclofen pump — For generalized spasticity affecting multiple limbs
  • Phenol nerve block / surgical neurectomy — For severe, refractory spasticity

Accurate MAS documentation with specific muscle-group grades and functional impact descriptions is essential for insurance authorization letters.

Reliability & Limitations

  • Interrater reliability: ICC = 0.82–0.87 when performed by trained clinicians using standardized speed and positioning
  • Test-retest reliability: ICC = 0.75–0.85 — moderate; improves significantly with training
  • Ordinal scale limitation: MAS grades are not equally spaced — the difference between grade 1 and 2 is not the same clinical magnitude as between 3 and 4
  • Velocity dependency: Inconsistent movement speed is the single biggest source of measurement error — always use gravity speed
  • MAS ≠ strength: High spasticity grade can coexist with severe muscle weakness (paresis). Do not confuse tone assessment with muscle strength testing.

MAS vs Other Spasticity Measures

  • vs Tardieu Scale: The Tardieu Scale is more sensitive to spasticity vs contracture distinction, using two speeds (slow and fast) to differentiate neural and non-neural components. MAS is faster to administer; Tardieu is more diagnostically specific.
  • vs Penn Spasm Frequency Scale: Penn measures frequency of spasm episodes, not passive resistance. MAS and Penn are complementary — use both for comprehensive spasticity documentation.
  • vs Fugl-Meyer Assessment: FMA measures overall motor recovery including synergy patterns and coordination; MAS specifically measures tone/spasticity. Both are used together in stroke rehabilitation.
Dr. Nikhil Mahajan, PT, MPT Doctor of Physical Therapy · Reviewed January 15, 2025 · View full credentials

Frequently Asked Questions

What is the difference between spasticity and rigidity on the MAS?
The MAS primarily measures spasticity — velocity-dependent resistance to passive stretch. Rigidity (as in Parkinson's disease) is velocity-independent and presents as consistent resistance throughout the full ROM regardless of speed. The MAS is less reliable for rating rigidity. Use the Unified Parkinson's Disease Rating Scale (UPDRS) for rigidity in Parkinson's patients.
Can the MAS be used in pediatric patients?
Yes. The MAS is widely used in pediatric neurology and cerebral palsy management. It is used to document spasticity severity, justify Botulinum toxin injections in children, and monitor outcomes after selective dorsal rhizotomy (SDR). The same grading criteria apply; cooperation and relaxation are more challenging in young children.
How often should MAS be reassessed after Botox injections?
Botulinum toxin effects typically peak at 4-6 weeks post-injection. MAS reassessment is recommended at 4-6 weeks to document treatment response. Repeat assessment at 3 months (typical Botox duration) to determine need for re-injection. Document pre-injection and post-injection grades for insurance and outcome tracking.
What factors affect MAS scores on the same day?
Spasticity is highly variable — it increases with arousal, anxiety, pain, cold temperature, full bladder, pressure sores, and fever. It decreases with relaxation, warmth, and sleep. Always standardize assessment time (ideally morning, resting state) and document any factors that may have influenced tone. MAS scores from different times of day are not reliably comparable.